Donor-Derived NK Cells Safe and Efficacious in Relapsed and Refractory AML
Donor-Derived NK Cells Safe and Efficacious in Relapsed and Refractory AML https://pediatricsnationwide.org/wp-content/uploads/2022/04/NK-Cell-Cover-Art-web-crop-1024x649.jpg 1024 649 Lauren Dembeck https://pediatricsnationwide.org/wp-content/uploads/2021/03/Dembeck_headshot.gif
Researchers have used their approach for growing large numbers of NK cells to allow repeated dosing for a more effective and less toxic treatment. Outcomes for patients with relapsed and refractory acute myeloid leukemia (R/R AML) have not significantly improved over the last 30 years. For example, a recent study of patients treated with…